Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice concerning the determination of conditions for issuance of stock option
Corporate Governance Report
Notice concerning issuance of stock options (stock acquisition rights)
Consolidated Financial Results for the Fiscal Year Ended July 31, 2025
Premier Anti-Aging, 50% Decrease in Ordinary Profit for The Current Fiscal Year
FY2025 Results Briefing Material
Notice concerning difference between consolidated earnings forecasts and actual results for FY2025 and the recording of deferred tax assets
Notice concerning reduction of share capital amount
Business Plan and Growth Potential Explanatory Material
FY2025 3Q Results Briefing Material
Notice concerning revision of full year consolidated earnings forecasts
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending July 31, 2025
Premier Anti-Aging, Ordinary Profit Forecast for the Fiscal Year Revised Upward to an Unexpected 55% Increase
[Delayed] Corporate Report 2025
Notice concerning difference between interim consolidated earnings forecasts and actual results for the six months ended January 31, 2025
FY2025 2Q Results Briefing Material
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending July 31, 2025
Premier Anti-Aging, First Half Ordinary Profit Turns to Profit, Exceeds Expectations, Exceeds Full-Year Plan
A new brand that realizes fast beauty medical concept, Lalaskin, is born! Advance sale on April 11, 2025, nationwide release on September 19, 2025.
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending July 31, 2025